Desjardins Clarissa's Form 4 filing
INSMED Inc (INSM) · filed May 22, 2025
- Accession no.
- 0001628280-25-027340
- Filed
- May 22, 2025
- Trade date
- May 20-21, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $201.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Desjardins ClarissaCIK 0001793390 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 20, 2025 | Common Stock | PPurchaseAcquired | +1,895 | $66.87F1 | +$126,718.65 | 1,895 | Indirect | |
| May 21, 2025 | Common Stock | PPurchaseAcquired | +1,130 | $66.35 | +$74,975.5 | 3,025 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This is the weighted average purchase price representing 1,895 shares purchased at prices ranging from $66.75 to $66.98 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.